What is the common link between gastroparesis, constipation, neuromyelitis optica (NMO), cholelithiasis, and fatigue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Gastroparesis, constipation, neuromyelitis optica, cholelithiasis, and fatigue can all be manifestations of autonomic nervous system dysfunction, and the most recent evidence suggests that addressing the underlying autonomic dysregulation is crucial for effective management. These conditions, while seemingly diverse, share connections through potential disruptions in the body's autonomic regulation. Gastroparesis involves delayed stomach emptying, while constipation reflects impaired intestinal motility - both regulated by autonomic nerves 1. Neuromyelitis optica, an autoimmune disorder affecting the optic nerves and spinal cord, can damage autonomic pathways 2. Cholelithiasis (gallstones) may be influenced by altered gallbladder motility, which is under autonomic control. Fatigue often accompanies autonomic dysfunction as the body struggles with basic regulatory functions like blood pressure control and energy management.

Some key points to consider in the management of these conditions include:

  • Comprehensive autonomic testing to identify the underlying dysregulation
  • Management approaches that address the underlying autonomic dysfunction, rather than treating each symptom in isolation
  • Medications that modulate autonomic function, such as pyridostigmine for motility issues or immunomodulators for autoimmune components, may be considered depending on the specific presentation and severity of symptoms 3
  • Recent advancements in the understanding of gastroparesis, including the role of innate immune dysregulation and injury to the interstitial cells of Cajal, may inform treatment strategies 3
  • Emerging treatments, such as antiemetics, prokinetics, and fundic relaxants, may offer new options for managing symptoms 3

Overall, a comprehensive approach that addresses the underlying autonomic dysfunction and considers the complex interplay between these conditions is essential for effective management and improving patient outcomes.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.